{"schema_version":"secwatch.filing_event.v1","accession":"0001801170-22-000032","form_type":"8-K","ticker":"CLOV","cik":"0001801170","company_name":"CLOVER HEALTH INVESTMENTS, CORP. /DE","filed_at":"2022-05-25T23:59:59+00:00","discovered_at":"2026-05-14T18:04:02.368422+00:00","generated_at":"2026-06-25T07:17:13.639189+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Clover Health appoints Scott J. Leffler as CFO effective August 2022","bullets":["Scott J. Leffler, former CFO of Sotera Health, named permanent CFO; starts August 2022.","Interim CFO Mark C. Herbers will assist transition after Leffler joins.","Base salary $500,000; target bonus 75%; one-time RSU grant worth $12,000,000 with graded vesting.","Signing bonus of $100,000 with repayment clause for voluntary termination within 12 months."],"urls":{"canonical":"https://secwatch.observer/filing/0001801170-22-000032","json":"https://secwatch.observer/filing/0001801170-22-000032.json","markdown":"https://secwatch.observer/filing/0001801170-22-000032.md","text":"https://secwatch.observer/filing/0001801170-22-000032.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1801170/000180117022000032/0001801170-22-000032-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1801170/000180117022000032/clov-20220525.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-25T07:17:13.639189+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"639ff3a52c","claim":"Scott J. Leffler was appointed as Chief Financial Officer at CLOVER HEALTH INVESTMENTS, CORP. /DE.","evidence_excerpt":"Scott J. Leffler will become Chief Financial Officer of the Company, to serve as the Company’s principal financial officer and principal accounting officer, effective upon the commencement of his employment with the Company in August 2022.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1801170/000180117022000032/0001801170-22-000032-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Financial Officer"}],"fact_type":"executive_change"},{"claim_id":"a51111dc12","claim":"Mark C. Herbers changed role as Interim Chief Financial Officer at CLOVER HEALTH INVESTMENTS, CORP. /DE.","evidence_excerpt":"Mr. Leffler will succeed Mark C. Herbers, the Company’s current Interim Chief Financial Officer, who will continue in his role as Interim Chief Financial Officer until Mr. Leffler joins the Company and thereafter will assist in the transition.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1801170/000180117022000032/0001801170-22-000032-index.htm","confidence":0.9,"family_label":"Executive change","details":[{"label":"Action","value":"succeeded"},{"label":"Role","value":"Interim Chief Financial Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}